Walker, Sarah, Goodfellow, Henry, Pookarnjanamorakot, Patra, Murray, Elizabeth, Bindman, Julia, Blandford, Ann, Bradbury, Katherine, Cooper, Belinda, Hamilton, Fiona L., Hurst, John R., Hylton, Hannah, Linke, Stuart, Pfeffer, Paul, Ricketts, William, Robson, Chris, Stevenson, Fiona A., Sunkersing, David, Wang, Jiunn, Gomes, Manuel and Henley, William , (2023) Impact of fatigue as the primary determinant of functional limitations among patients with post-COVID-19 syndome: a cross=sectional observational study: A cross-sectional observational study. BMJ Open, 13 (6), [e069217]. (doi:10.1136/bmjopen-2022-069217).
Abstract
Objectives: to describe self-reported characteristics and symptoms of treatment-seeking patients with post-COVID-19 syndrome (PCS). To assess the impact of symptoms on health-related quality of life (HRQoL) and patients’ ability to work and undertake activities of daily living.
Design: cross-sectional single-arm service evaluation of real-time user data.
Setting: 31 post-COVID-19 clinics in the UK.
Participants: 3754 adults diagnosed with PCS in primary or secondary care deemed suitable for rehabilitation.
Intervention: patients using the Living With Covid Recovery digital health intervention registered between 30 November 2020 and 23 March 2022.
Primary and secondary outcome measures: the primary outcome was the baseline Work and Social Adjustment Scale (WSAS). WSAS measures the functional limitations of the patient; scores of ≥20 indicate moderately severe limitations. Other symptoms explored included fatigue (Functional Assessment of Chronic Illness Therapy–Fatigue), depression (Patient Health Questionnaire–Eight Item Depression Scale), anxiety (Generalised Anxiety Disorder Scale, Seven-Item), breathlessness (Medical Research Council Dyspnoea Scale and Dyspnoea-12), cognitive impairment (Perceived Deficits Questionnaire, Five-Item Version) and HRQoL (EQ-5D). Symptoms and demographic characteristics associated with more severe functional limitations were identified using logistic regression analysis.
Results: 3541 (94%) patients were of working age (18-65); mean age (SD) 48 (12) years; 1282 (71%) were female and 89% were white. 51% reported losing ≥1 days from work in the previous 4 weeks; 20% reported being unable to work at all. Mean WSAS score at baseline was 21 (SD 10) with 53% scoring ≥20. Factors associated with WSAS scores of ≥20 were high levels of fatigue, depression and cognitive impairment. Fatigue was found to be the main symptom contributing to a high WSAS score.
Conclusion: a high proportion of this PCS treatment-seeking population was of working age with over half reporting moderately severe or worse functional limitation. There were substantial impacts on ability to work and activities of daily living in people with PCS. Clinical care and rehabilitation should address the management of fatigue as the dominant symptom explaining variation in functionality.
More information
Identifiers
Catalogue record
Export record
Altmetrics
Contributors
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.